Journal Maturitas publishes position statement on management of uterine fibroids

Journal Maturitas today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) on the topic of the management of uterine fibroids.

Uterine fibroids (also termed leiomyomas or myomas) are the most common tumors of the . While they may be asymptomatic they can cause abnormal bleeding, pelvic pressure symptoms and infertility. Fibroid growth and regression vary throughout life. Thus, they tend to grow during the reproductive years and regress after the menopause. They affect millions of women and are the leading cause of hysterectomy.

The traditional management of symptomatic fibroids has been surgery (hysterectomy or myomectomy). However, some women do not want invasive surgery and wish to retain their uterus and fertility. Fortunately, during the last few years new medical and surgical uterine-conserving alternatives have become available as technological advances have been made. The range of medical treatments allows flexible management of fibroid-related symptoms; the options include tranexamic acid, non-steroidal anti-inflammatory drugs, contraceptive steroids, gonadotropin-releasing hormone analogues, antiprogesterone, and selective progesterone receptor modulators. Alternatives to surgery include uterine artery embolization, myolysis and ablation by high-intensity focused ultrasound (guided with or ultrasound). The choice of treatment depends on fibroid size, the underlying symptoms and their severity and the woman's desire for subsequent fertility and pregnancy, as well as efficacy and need for repeated interventions.

These and other recommendations presented in EMAS' position statement are published in the article, "EMAS Position statement: Management of " by, Faustino R. Pérez-López, Lía Ornat, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Irene Lambrinoudaki, Karin Schenck-Gustafsson, Tommaso Simoncini, Florence Tremollieres and Margaret Rees.

More information: "EMAS Position statement: Management of uterine fibroids" by, Faustino R. Pérez-López, Lía Ornat, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Irene Lambrinoudaki, Karin Schenck-Gustafsson, Tommaso Simoncini, Florence Tremollieres and Margaret Rees. www.maturitas.org/article/S037… (14)00198-4/abstract

add to favorites email to friend print save as pdf

Related Stories

Fibroids are common problem for women

Apr 01, 2014

Uterine fibroids are very common, occurring in as many as 50 percent of women in their reproductive years and up to two-thirds of women by the time they go through menopause. While many fibroids cause no problems and require ...

Genetic risk for uterine fibroids discovered

Oct 04, 2012

Uterine fibroids are the most common type of pelvic tumors in women and are the leading cause of hysterectomy in the United States. Researchers from Brigham and Women's Hospital (BWH) are the first to discover a genetic risk ...

Recommended for you

NY and NJ say they will require Ebola quarantines

2 hours ago

The governors of New Jersey and New York on Friday ordered a mandatory, 21-day quarantine for all doctors and other arriving travelers who have had contact with Ebola victims in West Africa.

WHO: Mali case may have infected many people

6 hours ago

The World Health Organization says a toddler who brought Ebola to Mali was bleeding from her nose during her journey on public transport and may have infected many people.

Two US nurses are declared cured of Ebola

7 hours ago

Two American nurses were declared cured of Ebola on Friday, and one was healthy enough to leave the hospital and meet President Barack Obama for a hug.

User comments